MedPath
PPB Approval

REMSIMA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG (KOREA)

HK-65013

Prescription only Medicines

March 2, 2017

Company Information

Company Details

SUITE 3305, 33RD FLOOR, TOWER 5, THE GATEWAY HARBOUR CITY, 15, CANTON ROAD, TSIM SHA TSUI, KOWLOON

Active Ingredients

infliximab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

REMSIMA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG (KOREA) - PPB 批准文号 | MedPath